Diagnosis and Management of Metastatic CRC: State-of-the-Art Oncology Nursing Practice Video

OncoLink Team
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: September 30, 2014

Share article


Diagnosis and Management of Metastatic CRC: State-of-the-Art Oncology Nursing Practice from OncoLink.

*Please view in HD for best slide quality.
To turn on HD, put your on-screen mouse pointer over the video box and click on the letters "HD" so that they are no longer gray.


View or Download a PDF of the Slides (Includes NCCN 1.2015 Guideline Update)

OncoLink CNE Diagnosis and Management of Metastatic CRC: State-of-the-Art Oncology Nursing Practice Post-Test


News
FOLFOXIRI + Bevacizumab Ups Outcome in Metastatic CRC

Oct 24, 2014 - For patients with untreated metastatic colorectal cancer, chemotherapy with fluorouracil, leucovorin, oxaliplatin, and irinotecan plus bevacizumab improves outcome versus fluorouracil, leucovorin, and irinotecan plus bevacizumab, according to a study published in the Oct. 23 issue of the New England Journal of Medicine.



OncoLink Treatment Binder

Select the side effects and forms for your patient's treatment binder

Learn More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More